Statistics

Total Visits

Views
miR-542-3p Attenuates Bone Loss and Marrow Adiposity Following Methotrexate Treatment by Targeting sFRP-1 and Smurf2 63

Total Visits per Month

November 2023 December 2023 January 2024 February 2024 March 2024 April 2024 May 2024
miR-542-3p Attenuates Bone Loss and Marrow Adiposity Following Methotrexate Treatment by Targeting sFRP-1 and Smurf2 6 5 0 0 4 2 8

File Downloads

Views
hdl_137534.pdf 23

Top Country Views

Views
United States 21
Vietnam 9
Belgium 5
Singapore 5
China 4
Germany 3
Argentina 1
Australia 1

Top City Views

Views
Hanoi 9
Ashburn 6
Brussels 5
Boardman 3
Singapore 3
New York 2